Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • ROOMS:

Gilead spending $50 million to test and manufacture COVID-19 drug candidate remdesivir

Gilead Sciences Inc. reported better-than-expected earnings for the first quarter of the year Thursday, and detailed more of its work on remdesivir, an antiviral drug candidate aimed at helping COVID-19 patients.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.